Clinical trial
Multicenter, Safety Study Of Maraviroc
NCT00478231 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00478231 |
|---|---|
| Title | Multicenter, Safety Study Of Maraviroc |
| Official title | A Multicenter, Open Label, Non-Comparative Safety Study Of Maraviroc |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, HIV Infection |
| Intervention type | Drug |
| Interventions | Maraviroc |
| Enrollment | 209 |
| Start date | Jul 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | May 24, 2007 |
| Last update posted | Sep 9, 2011 |
| Countries | Brazil |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: